2022. Repurposing Mitragynine as Anti-SARS-CoV-2 Agent Evidenced by In Silico Predictive Approach. Malaysian Journal of Fundamental and Applied Sciences. 18, 6 (Dec. 2022), 644–653. DOI:https://doi.org/10.11113/mjfas.v18n6.2637.